August 19, 2017 6:25 AM ET


Company Overview of YM BioSciences Inc.

Key Executives for YM BioSciences Inc.

NameBoard RelationshipsTitleAge
Lenord Vernon B.Sc. C.A4 RelationshipsVice President of Finance & Administration73
Ali Raza M.D.No RelationshipsPresident of Aerolef Division59
Jennifer Ellis No RelationshipsHead of Regulatory Affairs--
Elizabeth Jenkins No RelationshipsPrincipal Regulatory Advisor--
John F. Waterfall Ph.D.No RelationshipsInterim Head of Program Management--

YM BioSciences Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas Ian Alexander Allen Q.C. F.C.I.Arb 52 RelationshipsUnisphere Waste Conversion Ltd.77
Mark Andrew Entwistle BA, MA 53 RelationshipsThe Endeavor Group, Inc.61
Tryon M. Williams B.Sc.(Math) 20 RelationshipsShoal Games Ltd.76
Rogerio C. Lilenbaum M.D., M.Sc. 66 RelationshipsNational Comprehensive Cancer Network, Inc.--
Catherine J. Mackey Ph.D. 120 RelationshipsCour Pharmaceutical Development Company, Inc.62
View All Board Members

YM BioSciences Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee B.Sc.(Math)Tryon M. Williams20 Relationships4 Executives
Compensation Committee BA, MAMark Andrew Entwistle53 Relationships2 Executives
Nominating Committee Q.C. F.C.I.ArbThomas Ian Alexander Allen52 Relationships2 Executives
Corporate Governance Committee Q.C. F.C.I.ArbThomas Ian Alexander Allen52 Relationships2 Executives
Advisory Board M.D., M.Sc.Rogerio C. Lilenbaum66 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
YM BioSciences Inc. CEO Compensation
Industry Average


RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET
Five Prime Therapeutics, Inc. Appoints Bryan Irving as Senior Vice President, Research, with Effect from September 1, 2017
August 17, 2017 8:05 PM ET
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub; Appoints Michael Scott as Senior Vice President of Product Development and Toronto Operations
August 17, 2017 12:00 PM ET
PsiOxus Therapeutics Announce Two New Board Members
August 17, 2017 7:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact YM BioSciences Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at